Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation
Ortega Sanchez, Stenner, Dirnhofer et al
Swiss Med Wkly (2019) 149, w20150
Generation of Tumor Cells Expressing Firefly Luciferase (fLuc) to Evaluate the Effectiveness of CAR in a Murine Model
de Souza Fernandes Pereira, Fantacini, Picanço-Castro
Methods Mol. Biol. (2020) 2086, 237-250
Determination of Cytotoxic Potential of CAR-T Cells in Co-cultivation Assays
Nacasaki Silvestre, Moço, Picanço-Castro
Methods Mol. Biol. (2020) 2086, 213-222
Immunophenotypic Analysis of CAR-T Cells
de Azevedo, Mizukami, Moço et al
Methods Mol. Biol. (2020) 2086, 195-201
Replication-Competent Lentivirus Analysis of Vector-Transduced T Cell Products Used in Cancer Immunotherapy Clinical Trials
Cornetta, Koop, Nance et al
Methods Mol. Biol. (2020) 2086, 181-194
CAR-T Cell Expansion in a Xuri Cell Expansion System W25
Smith
Methods Mol. Biol. (2020) 2086, 151-163
Platforms for Clinical-Grade CAR-T Cell Expansion
Mizukami, Swiech
Methods Mol. Biol. (2020) 2086, 139-150
Generation of CAR+ T Lymphocytes Using the Sleeping Beauty Transposon System
Chicaybam, Abdo, Bonamino
Methods Mol. Biol. (2020) 2086, 131-137
In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development
Androulla, Lefkothea
Methods Mol. Biol. (2020) 2086, 87-117
CAR-T Cells for Cancer Treatment: Current Design and Next Frontiers
Picanço-Castro, Swiech, Malmegrim et al
Methods Mol. Biol. (2020) 2086, 1-10
A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies
Guo, Alexander, Dib et al
Eur. J. Cancer (2019) 124, 15-24
IgE-binding epitope mapping of tropomyosin allergen (Exo m 1) from Exopalaemon modestus, the freshwater Siberian prawn
Zhang, Li, Xiao et al
Food Chem (2019) 309, 125603
Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan
Miyamura, Kudo, Tabuchi et al
Leuk. Res. (2019) 87, 106263
Biological regulation of diacylglycerol kinases in normal and neoplastic tissues: New opportunities for cancer immunotherapy
Arranz-Nicolás, Mérida
Adv Biol Regul (2019)
Tissue Site and the Cancer Immunity Cycle
Horton, Fessenden, Spranger
Trends Cancer (2019) 5, 593-603
Paving New Roads for CARs
Hyrenius-Wittsten, Roybal
Trends Cancer (2019) 5, 583-592
Peanut Oral Immunotherapy: Is It Safer in Preschoolers than in Older Age Groups?
Rachid
J Allergy Clin Immunol Pract (2019) 7, 2768-2769
Challenges in Clinical Trial Design for T Cell-Based Cancer Immunotherapy
Kruger, Cadilha, von Bergwelt-Baildon et al
Clin. Pharmacol. Ther. (2019)
Targeted Therapy and Immunotherapy: Emerging Biomarkers in Metastatic Melanoma
LoRusso, Schalper, Sosman
Pigment Cell Melanoma Res (2019)
Chimeric antigen-receptor (CAR) T cells: The revolution of the cell and personalized therapy for cancer
Briones-Meijide
Farm Hosp (2019) 43, 173-174